From breast cancer cell homing to the onset of early bone metastasis: The role of bone (re)modeling in early lesion formation
Science Advances · 2024-02-23 · 10 (8)
DOI: 10.1126/sciadv.adj0975 ↗At a glance
Journal article in Science Advances, published on 2024-02-23. Written by Sarah A E Young and 9 co-authors. Institution: Department of Biomaterials, Max Planck Institute of Colloids and Interfaces, Potsdam, Germany. Major MEDLINE topics: Bone Neoplasms, Osteolysis. Cited 22 times so far (Crossref); 43 references. The full text is freely available in PubMed Central.
Abstract (original language)
Breast cancer often metastasizes to bone, causing osteolytic lesions. Structural and biophysical changes are rarely studied yet are hypothesized to influence metastasis. We developed a mouse model of early bone metastasis and multimodal imaging to quantify cancer cell homing, bone (re)modeling, and onset of metastasis. Using tissue clearing and three-dimensional (3D) light sheet fluorescence microscopy, we located enhanced green fluorescent protein–positive cancer cells and small clusters in intact bones and quantified their size and spatial distribution. We detected early bone lesions using in vivo microcomputed tomography (microCT)–based time-lapse morphometry and revealed altered bone (re)modeling in the absence of detectable lesions. With a new microCT image analysis tool, we tracked the growth of early lesions over time. We showed that cancer cells home in all bone compartments, while osteolytic lesions are only detected in the metaphysis, a region of high (re)modeling. Our study suggests that higher rates of (re)modeling act as a driver of lesion formation during early metastasis.
Subjects
MeSH terms (MEDLINE)
Authors and institutions
- Department of Biomaterials, Max Planck Institute of Colloids and Interfaces, Potsdam, Germany.
- Research Centre, Shriners Hospital for Children-Canada, Faculty of Dental Medicine and Oral Health Sciences, McGill University, Montreal, Canada.
- Julius Wolff Institute, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Germany.
- Leibniz-Institute for Advancing Analytics - ISAS - e.V., Dortmund, Germany.
- Group of Bioengineering in Regeneration and Cancer, Biodonostia Health Research Institute, San Sebastian, Spain.
- IKERBASQUE, Basque Foundation for Science, Bilbao, Spain.
ORCID profiles: Sarah A E Young, Anna-Dorothea Heller, Daniela S Garske, Maximilian Rummler, Victoria Qian, Agnes Ellinghaus, Georg N Duda, Bettina M Willie, Anika Grüneboom, Amaia Cipitria
Cite
APA
Young, S. A. E., Heller, A. D., Garske, D. S., Rummler, M., Qian, V., Ellinghaus, A., Duda, G. N., Willie, B. M., Grüneboom, A., & Cipitria, A. (2024). From breast cancer cell homing to the onset of early bone metastasis: The role of bone (re)modeling in early lesion formation. Science Advances, 10(8). https://doi.org/10.1126/sciadv.adj0975
Vancouver
Young SAE, Heller AD, Garske DS, Rummler M, Qian V, Ellinghaus A, et al. From breast cancer cell homing to the onset of early bone metastasis: The role of bone (re)modeling in early lesion formation. Science Advances. 2024;10(8). doi:10.1126/sciadv.adj0975
BibTeX
@article{Young2024,
author = {Young, Sarah A E and Heller, Anna-Dorothea and Garske, Daniela S and Rummler, Maximilian and Qian, Victoria and Ellinghaus, Agnes and Duda, Georg N and Willie, Bettina M and Grüneboom, Anika and Cipitria, Amaia},
title = {From breast cancer cell homing to the onset of early bone metastasis: The role of bone (re)modeling in early lesion formation},
journal = {Science Advances},
year = {2024},
volume = {10},
number = {8},
doi = {10.1126/sciadv.adj0975}
}
EUVIMED